EssentialeTM – L 1g
NATTERMAN

Lecithin
Lecithin provides Essential Phospholipids for a healthy liver#
 Each Serving (Soft Gelatin Capsule) Contains: % RDA
Lecithin 1000 mg *
*No RDA established under ICMR

(Approx. Values) Per serving / One Soft Gelatin Capsule (Wt. 1.380 g)
Energy: 9.20 Kcal
Protein: 0.04 g
Carbohydrate: 0.01 g
Sugar: 0.00 g
Fat: 0.98 g
Saturated Fat content: 0.

21 g
Trans Fat Content: 0.11 g

Adults: 1-2 Capsules per day to be taken with meals.
Not to exceed the stated recommended daily usage

Strips of 10 capsules.
Best before 24 months from manufacture

NUTRACEUTICAL
NOT FOR MEDICINAL USE.

Geltec Private Ltd.
At: Sr. No. 24, 26/3, 27/2, Yadavanahalli, Attibele, Bangalore – Hosur Road, Bangalore – 562 107, Karnataka, Regd. Office: Capsulation Premises, Deonar, Sion-Trombay Road, Mumbai-400 088
FSSAI License No: 10013043000559

Abbott Healthcare Pvt Ltd
Angel Space, Bldg. D-4, Gala No. 1 to 6 & 11 to 16 Ground Floor, 101 to 106 & 111 to 116 First Floor, 201 to 206 & 211 to 216, 2nd Floor, Pimplas, Dist. Thane, Bhiwandi – 421 302, Maharashtra, India.

FSSAI License No: 10015022003952.
 For feedback / queries contact customer care office at the above Marketing office address or at email: webmasterindia@abbott.com or Tel. No 18002127476
TM Essentiale Natterman is a Trade Mark of Natterman International GMBH West Germany

Not recommended in pregnancy and lactation
Keep out of reach of children
Please consult your healthcare professional if you are under any treatment.

Essentiale L 1g is generally well tolerated. Some of the possible adverse reactions with Essentiale L 1g can be gastric discomfort and mild diarrhea.
Storage conditions: Store in a dry place below 25°C.

Protect from direct sunlight.

Gundermann KJ et al., Essential phospholipids in fatty liver: a scientific update; Clinical and Experimental Gastroenterology 2016:9 105-117
Gundermann KJ et al, Activity of essential phospholipids (EPL) from soybean in liver diseases, Pharmacol Rep.

2011;63(3):643-59
Narsimulu G (ed.). Role of Essential Phospholipids in various Liver disorders. Delhi: Thieme Publishing; 2019 Gundermann KJ. and Schumacher R., 50th Anniversary of Phospholipid Research (EPL), International Symposium, Cologne, Dec 1989 5.
Dajani A.I., Popovic B., Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis; World J Clin Cases 2020 Nov 6; 8(21): 5235-5249

©2025 Abbott, All Rights Reserved.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.